NE HEALTH BUREAU
CHENNAI, FEB 10
Chennai’s VS Hospitals and VS Medical Trust on Saturday announced the commencement of the two-day VS International Precision Oncology Summit (VIPOS 2024), at Ramada Plaza, Guindy, Chennai. This groundbreaking event marks a pivotal moment in cancer care, assembling a global community of oncology experts to foster collaboration and innovation in the fight against cancer.
The summit’s inauguration, led by renowned figures in the medical field, sets the stage for a comprehensive exploration of the latest advancements in precision oncology. VIPOS 2024 aims to catalyze transformative progress in cancer treatment, emphasizing the importance of screening, diagnostics, prognostics, therapeutics, and comprehensive care.
- Over 100 Faculties and more than 200 delegates from esteemed cancer centers are participating in this event, making it a significant gathering for the oncology community
- Prof. Dr. S. Subramanian, the summit’s Program Director, and Organising Chairperson emphasizes the importance of this event as a step forward in personalizing cancer treatment through cutting-edge technologies and therapies
- Prof Dr S Sundar, Medical Director, VS Group of Hospitals, and S Muthu Subramanian, Executive Director, VS Group of Hospitals underscore the VS Group’s commitment to advancing oncology through innovation and collaboration
- Dr. Sankar Srinivasan and Dr. K. Kalaichelvi, Medical Oncologists from Apollo Hospitals, Chennai, join the panel, bringing invaluable insights and expertise to the discussions
Over 100 Faculties and more than 200 delegates from esteemed cancer centers are participating in this event, making it a significant gathering for the oncology community. Discussions will span the most recent research and innovations, including Hematological Malignancies like Lymphomas, Leukemias, Myelomas, Hodgkin’s Disease, MDS, Solid Tumours like Breast, Lungs, Head and Neck, Colon, Prostate, Immunotherapy, Targeted Therapies, Liquid Biopsy and many others, highlighting the summit’s role in shaping future cancer care strategies.
Prof. Dr. S. Subramanian, the Senior Most Practising Medical Oncologist in India, the summit’s Program Director, and Organising Chairperson emphasized the importance of this event as a step forward in personalizing cancer treatment through cutting-edge technologies and therapies. He highlighted the summit’s role in fostering a collaborative environment for clinicians and researchers, driving forward the evolution of oncology care.
Echoing the sentiment, Prof. Dr. S. Sundar, Medical Director, VS Group of Hospitals, and Mr. S. Muthu Subramanian, Executive Director, VS Group of Hospitals underscored the VS Group’s commitment to advancing oncology through innovation and collaboration. They expressed their anticipation for the outcomes of the summit, which promises to impact cancer care positively, offering new hope and possibilities for patients worldwide.
Adding to the distinguished lineup, Dr. Sankar Srinivasan and Dr. K. Kalaichelvi, esteemed Medical Oncologists from Apollo Hospitals, Chennai, join the panel, bringing invaluable insights and expertise to the discussions.
VIPOS 2024 embodies the collective endeavor to redefine cancer treatment, emphasizing personalized care and the integration of the latest scientific breakthroughs. As the summit unfolds, it stands as a testament to the relentless pursuit of excellence in oncology, heralding a new era of hope and healing for cancer patients across the globe.
